1263 related articles for article (PubMed ID: 26511749)
21. Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase
Koksal E; Tulek N; Sonmezer MC; Temocin F; Bulut C; Hatipoglu C; Erdinc FS; Ertem G
Investig Clin Urol; 2019 Jan; 60(1):46-53. PubMed ID: 30637361
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
[TBL] [Abstract][Full Text] [Related]
26. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
Jansåker F; Frimodt-Møller N; Sjögren I; Dahl Knudsen J
J Antimicrob Chemother; 2014 Mar; 69(3):769-72. PubMed ID: 24107388
[TBL] [Abstract][Full Text] [Related]
27. [Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region].
Marijan T; Plecko V; Vranes J; Dzepina AM; Bedenić B; Kalenić S
Med Glas (Zenica); 2010 Feb; 7(1):46-53. PubMed ID: 20387724
[TBL] [Abstract][Full Text] [Related]
28. Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi.
Taneja J; Mishra B; Thakur A; Dogra V; Loomba P
J Infect Dev Ctries; 2010 Sep; 4(8):517-20. PubMed ID: 20818104
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Laboratory Profile of Urinary Tract Infections Associated with Extended Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae.
Al Yousef SA; Younis S; Farrag E; Moussa HSh; Bayoumi FS; Ali AM
Ann Clin Lab Sci; 2016 Jul; 46(4):393-400. PubMed ID: 27466299
[TBL] [Abstract][Full Text] [Related]
30. Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
Johnson JK; Robinson GL; Pineles LL; Ajao AO; Zhao L; Albrecht JS; Harris AD; Thom KA; Furuno JP
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167543
[TBL] [Abstract][Full Text] [Related]
31. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
32. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
33. Association of high mortality with extended-spectrum β-lactamase (ESBL) positive cultures in community acquired infections.
Ray S; Anand D; Purwar S; Samanta A; Upadhye KV; Gupta P; Dhar D
J Crit Care; 2018 Apr; 44():255-260. PubMed ID: 29220754
[TBL] [Abstract][Full Text] [Related]
34. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
[TBL] [Abstract][Full Text] [Related]
35. [Extended-spectrum β-lactamase producing bacilli in a paediatric hospital].
Dias A; Oliveira G; Oliveira H; Marques M; Rodrigues F
Acta Med Port; 2011 Dec; 24 Suppl 2():197-206. PubMed ID: 22849904
[TBL] [Abstract][Full Text] [Related]
36. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of antibiotic treatments for urinary tract infections in the elderly, especially regarding the effect on extended spectrum β-lactamase producing (ESBL-) Escherichia coli: A comparison between meropenem and alternatives].
Yamamoto A; Yamasaki K
Nihon Ronen Igakkai Zasshi; 2015; 52(2):153-61. PubMed ID: 25994987
[TBL] [Abstract][Full Text] [Related]
38. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
Khanfar HS; Bindayna KM; Senok AC; Botta GA
J Infect Dev Ctries; 2009 May; 3(4):295-9. PubMed ID: 19759493
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
Chaudhary P; Bhandari D; Thapa K; Thapa P; Shrestha D; Chaudhary HK; Shrestha A; Parajuli H; Gupta BP
J Nepal Health Res Counc; 2016 May; 14(33):111-115. PubMed ID: 27885293
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases of Escherichia coli and Klebsiella spp. Isolates from Urinary Tract Infections in Southern Brazil.
Pereira JL; Volcão LM; Klafke GB; Vieira RS; Gonçalves CV; Ramis IB; da Silva PEA; von Groll A
Microb Drug Resist; 2019 Mar; 25(2):173-181. PubMed ID: 30133334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]